Lindsay Rosenwald & Money Central Article
In this report, Michael Brush, writer for MSN’s Money Central, talks about the benefits of examining industry insiders when making decisions for your stock portfolio. He notes the records of major industry insiders in the past, with the notable “Insider Portfolio” beating the Dow Jones by over 900% over the 1986 to 2010 stretch. The advice is relatively straightforward – buy what those in the know are buying, and sell what and when they’re selling.
Brush then continues to examine big hitters within the industry, mentioning Tom Ward of Chesapeake Energy and Lindsay Rosenwald.. He praises choices from both insiders, and mentions the Lindsay Rosenwald’s impressive record (with gains of 100% to 280% over a si month period, and short trades in two stocks hitting over a 60% gain).
Brush specifies specific stocks that Rosenwald, Ward, and other insiders are investing heavily in, mentioning potential up and comers in various industries. Brush also looks at Lindsay Rosenwald’s selling record (as well as the selling record of other insiders) in order to see a pattern of what may be wise to drop.
The article proceeds to mention Lindsay Rosenwald‘s background as a venture capitalist, and his work in the finance and medical industries. He talks about the longer track record that gives Rosenwald some definite bragging rights when it comes to investment in the Biotech industry. He goes into detail on one recent investment (in the company Genta) and what it may mean for potential investors in the industry.
Michael Brush goes into detail on the background of other investors and their major investments (as well as payoffs), including Tom Ward, Phillip Frost, David Rafael Lewis, Shahin Hedayat, Thomas Smach, and Naveen Jain. In the list, he calls Lindsay Rosenwald the “top all-star.”
Related posts:
[...] has successfully raised nearly one billion dollars since its inception. With the company, Dr. Lindsay Rosenwald started numerous companies that are into advanced drug development and clinical [...]